Evidence for parent of origin effect in late-onset Alzheimer disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 114, Issue 6, 2002, Pages 679-686

  Bassett, Susan Spear ^a,c   Avramopoulos, Dimitrios ^a   Fallin, Daniele ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Family history; Genetic imprinting; Maternal transmission

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 19; CHROMOSOME 20; DATA ANALYSIS; DIAGNOSTIC VALUE; DISEASE TRANSMISSION; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MAPPING; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARENT; PRIORITY JOURNAL; SCORING SYSTEM; CHROMOSOME MAP; FATHER; GENETIC LINKAGE; GENETICS; GENOME IMPRINTING; GENOTYPE; MOTHER; STATISTICAL MODEL;

AGE OF ONSET; ALZHEIMER DISEASE; CHROMOSOME MAPPING; FATHERS; FEMALE; GENOMIC IMPRINTING; GENOTYPE; HUMAN; LINKAGE (GENETICS); LOD SCORE; MALE; MICROSATELLITE REPEATS; MODELS, STATISTICAL; MOTHERS; SUPPORT, U.S. GOV'T, P.H.S.; HUMANS;

MICROSATELLITE DNA;

EID: 0037043838     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.10648     Document Type: Article

References (46)

1. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer disease but is not causative
2. Results of a high resolution genome screen in 443 alzheimer disease families: The NIMH genetics initiative
3. APOE-4 and age-at-onset of Alzheimer disease: The NIMH Genetics Initiative
4. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
5. Mitochondrial involvement in Alzheimer disease
6. Familial nature of Alzheimer disease
7. Familial aggregation in Alzheimer disease: Comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations
8. Projections of Alzheimer disease in the United States and the public health impact of delaying disease onset
9. Familial aggregation of Alzheimer disease among whites, African-Americans, and Caribbean Hispanics in northern Manhattan
10. A comparison of familial and sporadic Alzheimer disease
11. Increased risk of dementia in mothers of Alzheimer disease cases: Evidence for maternal inheritance
12. Genetic epidemiological study of maternal and paternal transmission of Alzheimer disease
13. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer disease pedigrees
14. Apolipoprotein E genotype and gender influence response to tacrine therapy
15. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer disease
16. Mitochondria and apoptosis
17. Genomic imprinting: Review and relevance to human diseases
18. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer disease in the Rotterdam Study
19. DNA methylation and epigenetic mechanisms
20. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer disease: A case-control study
21. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample
22. A validation study of the Dementia Questionnaire
23. A full genome scan for late onset Alzheimer disease
24. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes
25. Parametric and nonparametric linkage analysis: A unified multipoint approach
26. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer disease
27. Genetic association studies between dementia of the Alzheimer type and three receptors for apolipoprotein E in a Caucasian population
28. A permutation procedure for the haplotype method for identification of disease-predisposing variants
29. Oxidative damage to mitochondrial DNA is increased in Alzheimer disease
30. Familial and population-based studies of apolipoprotein E and Alzheimer disease
31. Susceptibility locus for Alzheimer disease on chromosome 10
32. Mitochondria and degenerative disorders
33. Differential chromosome sensitivity to 5-azacytidine in Alzheimer disease
34. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12
35. Identification of novel genes in late-onset Alzheimer disease
36. The apolipoprotein E ε4 allele and the response to tacrine therapy in Alzheimer disease
37. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity
38. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: Potential genetic and phenotypic heterogeneity
39. Reliability of the family history method in genetic studies of Alzheimer disease and related dementias
40. A study of the reliability of the family history method in genetic studies of Alzheimer disease
41. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
42. Epidemiology of the dementias: Recent developments and new approaches
43. Familial aggregation of Alzheimer disease and related disorders: A collaborative re-analysis of case-control studies
44. Apolipoprotein E genotype and association between smoking and early onset Alzheimer disease
45. The number of trait loci in late-onset Alzheimer disease
46. Genetic studies on chromosome 12 in late-onset Alzheimer disease